Arbutus Biopharma Corporation (NASDAQ: ABUS): Arbutus Biopharma’s Strategy in Biotechnology

Arbutus Biopharma Corporation (NASDAQ: ABUS) is a clinical-stage biopharmaceutical company headquartered in Warminster, Pennsylvania, focused on developing innovative therapies to treat chronic hepatitis B virus (HBV) infection. The company aims to achieve a functional cure for HBV by targeting multiple…

Similar Posts